• COVID Vaccine Trials Offer Lessons For Improving Clinical Trial Diversity

    Clinical Research News | Concerted effort was required to ensure equitable inclusion of Black, Indigenous, and People Of Color (BIPOC) communities in COVID-19 vaccine trials—a complete reversal relative to historic norms. It would have been an impossibility without temporarily slowing or halting enrollment of White individuals so that the demographic composition at final enrollment closely mirrored the larger U.S. population.

    Nov 16, 2021

  • On The Tragic Passing Of Medidata’s Glen de Vries

    Clinical Research News | All of us at Cambridge Healthtech Institute, including the staff of Clinical Research News and the SCOPE conference team, are deeply saddened by last week’s tragic passing of Medidata co-founder Glen de Vries in a small plane crash in New Jersey. Encounters with the clinical trial visionary were always a privilege both for the learning opportunity and because of his especially friendly demeanor.

    Nov 15, 2021

  • Advances In Precision Medicine And Artificial Intelligence Are Set To Transform Cancer Treatment

    Clinical Research News | It’s time for healthcare organizations to open clinical trial options to patients at the beginning of the patient journey, not the terminus.

    Nov 12, 2021

  • What’s Behind Growing Adoption Of Cell-Based Vaccine Platforms

    Clinical Research News | Cell-based vaccines, initially developed to add speed and scale to pandemic response efforts and reduce dependency on chickens in the vaccine manufacturing process, have over the past few years also shown to be more reliably effective than traditional, egg-based products.

    Nov 10, 2021

  • ERT, Bioclinica Rebrand As Clario

    Clinical Research News | ERT today announced that following its early Q2 merger with Bioclinica, the combined company is renamed Clario.

    Nov 3, 2021

  • Follow the Money: Decentralized Trials, Security, COVID Research

    Clinical Research News | Medable’s big Series D, cryptographic data privacy, lung research, collaborative research and more.

    Nov 2, 2021

  • Science 37 Announces Two Partnerships in Japan, Veeva Launches Digital Trials Platform, More

    Clinical Research News | THREAD expands to Europe, Middle East and Africa, TD2 adopts Medidata’s Rave CTMS, Genesis Research enhances its healthcare literature research platform, and RealTime Software improves digital signatures. Plus new products from Trialbee, Vivacare, AliveCor, and more.

    Oct 29, 2021

  • Bringing The Fight To Antimicrobial Resistance: What COVID-19 Has Taught Us About How To Face A Growing Emergency

    Clinical Research News | Even as we make large strides toward the end of the pandemic, there is another growing global health crisis: antimicrobial resistance (AMR). The World Health Organization (WHO) calls AMR one of the top ten public health threats. There is an urgent need to focus on combating the health threat of AMR. The COVID-19 crisis, and the ensuing race to find treatments, has offered innovative and insightful approaches to implementing successful clinical trials related to infectious disease.

    Oct 27, 2021

  • Data-Sharing Platform Aims To Speed Drug Development For Rare Diseases

    Clinical Research News | The Critical Path Institute (C-Path) recently debuted a first-of-its-kind Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) to encourage data-sharing and collaboration among investigators to accelerate treatment innovation for rare diseases. The ultimate value of the platform will be in getting drugs approved quicker.

    Oct 25, 2021

  • Adverse Event Reporting May Need A Total Redo

    Clinical Research News | The reporting of adverse events (AEs) in randomized controlled trials (RCTs) has only modestly improved over the past two decades. But more consistent inclusion of AEs in published studies will not, by itself, provide a balanced picture of the potential harms of interventions.

    Oct 20, 2021

  • Global Consensus Building On Core Outcome Set For ‘Long COVID’ Studies

    Clinical Research News | By the end of this year, consensus by a global coalition of researchers, healthcare providers, and patients on a core set of outcomes that should be included in all future studies of post-COVID syndrome—so-called “long COVID”—are expected to be publicly released. A core outcome set (COS) is urgently needed to optimize and standardize clinical data collection and reporting across clinical trials for the condition.

    Oct 19, 2021

  • How Decentralized Trials Make Research More Accessible and Inclusive for Participants and Sites

    Clinical Research News | Traditionally designed clinical trials chronically struggle to enroll representative patient populations that will yield the comprehensive data needed to ensure that a new treatment will be safe and effective for everyone. I’ve been excited to watch decentralized clinical trial (DCT) approaches become more widely adopted because of their potential to democratize access to research. In order to produce the most accurate and reliable data about each new drug’s efficacy and safety, we have to meet participants and under-resourced sites where they are.

    Oct 15, 2021

  • How Pfizer Used Intelligent Machines to Take on Clinical Data

    Clinical Research News | Data determines AI feasibility, explained Prasanna Rao, Head of AI and Data Science at Pfizer. Formerly of IBM Watson, Rao outlined Pfizer’s recent experience implementing AI tools to aid with clinical data management at last month’s Bio-IT World Conference & Expo.

    Oct 12, 2021

  • Follow the Money: Virtual Care, Diversity in Trials, Personalized Medicine Plans

    Clinical Research News | Investments in virtual care, clinical trials for children and pregnant women, incentivizing diverse researchers to use the All of Us dataset, and more.

    Oct 11, 2021

  • Decentralized Trials & Research Alliance Grows, Partnerships in Site Conduct, Trial Diversity, More

    Clinical Research News | Decentralized trials around the world; partnerships with Eli Lilly, Great Ormond Street Hospital for Children, UNC Chapel Hill, Bristol Myers Squibb; and mergers and acquisitions. Plus: new products from Sensyne Health, Egnyte, and more.

    Oct 7, 2021

  • Experts Say Surrogate Endpoints Need More Regulatory Oversight

    Clinical Research News | “The benefits of using surrogate endpoints in drug trials are often outweighed by the harms of not knowing in a timely manner whether a new drug is effective in improving patient-relevant outcomes,” according to Huseyin Naci, associate professor of health policy at the London School of Economics and Political Science. Drugs approved based on surrogate endpoints—indirect measures for predicting outcomes such as laboratory values and radiographic images or, in oncology, response rates and disease-free survival—are sometimes later found to be ineffective or harmful.

    Oct 4, 2021

  • The Case For Considering Sex And Gender In Clinical Studies

    Clinical Research News | Researchers in Europe have found that most COVID-19 clinical trials to date have paid scant attention to the impact of sex and gender on the efficacy of pharmacological interventions—even after it became clear that those variables could have a striking effect on the outcomes of infected individuals. The findings could help make the case for “more and clearer regulations” around sex- and gender-sensitive analysis of study results.

    Sep 27, 2021

  • Clinical Trial Trends: 18 Months of Faster Tech Adoption, Real World Data, Increased Collaboration

    Clinical Research News | Namita Limaye, Research VP at IDC, gave a broad overview of IDC’s survey findings over the past 18 months at this week’s Bio-IT World Conference and Expo held in Boston and online. She highlighted trends in the life sciences and clinical trials industries that included increased collaboration, speedier adoption of technologies, reliance on real world data, and more.

    Sep 22, 2021

  • Machine Learning Adds Speed To Electronic Health Records-Based Phenotyping

    Clinical Research News | In clinical informatics research, creation of rule-based algorithms is a robust method for mining electronic health records (EHRs) to classify diagnoses. But the process requires considerable time and expertise to build, refine, and deploy, which explains why to date only 81 phenotypes have a publicly available algorithm.

    Sep 21, 2021

  • Real-World Data Suggests Statins Would Effectively Treat Ulcerative Colitis

    Clinical Research News | Researchers at Stanford have published close to 100 papers demonstrating that publicly-available data can be tapped to accelerate clinical translation. They have now integrated real-world molecular and clinical data to show, with astonishing clarity, that statins—the commonly prescribed cholesterol-lowering drug—would be an effective, if unexpected, treatment for ulcerative colitis (UC).

    Sep 16, 2021